Plasmid Specialisation Modules, Microbial Husbandry And Microbiome Resilience
Funder
National Health and Medical Research Council
Funding Amount
$645,005.00
Summary
The epidemiology of plasmids is chiefly determined by small genetic modules that control their entry to cells, their stability after entry, and their capacity to exclude other related plasmids. Understanding this is important for understanding transmission of antibiotic resistance. It is also essential for our newly proven approach to remove resistance plasmids from bacteria.
Harnessing The Type VI Secretion System ‘combat’ Arsenal Of A. Baumannii As A Source Of New Antimicrobials And Antimicrobial Targets
Funder
National Health and Medical Research Council
Funding Amount
$521,557.00
Summary
Infections caused by drug-resistant bacteria represent one of the greatest threats to human health. There is an urgent need to develop novel drugs and treatment strategies to combat infections by these drug-resistant organisms. We have shown that the bacteria A. baumannii uses a needle-like system to deliver lethal toxins into competitors. We will characterize these toxins so that we can manipulate them as weapons for controlling infections with multi-drug resistant bacteria.
New Candidate Vaccines To Prevent Tuberculosis: Preclinical Assessment Of Efficacy, Safety And Mechanism Of Protection
Funder
National Health and Medical Research Council
Funding Amount
$594,133.00
Summary
Almost two million people die from tuberculosis (TB) each year. The curent vaccine, BCG, is ineffective at controlling TB and and the type of immune response needed to protect against the disease is poorly understood. We have discovered new antigens of the TB bacterium, and we will combine them with our innovative vaccine technology to develop new vaccines to control TB. We will also try and understand why BCG is not effective, and use this information to further improve TB vaccination.
Severe sepsis is characterised by organ dysfunction secondary to infection, typically bacterial. We will quantify bacteria in the bloodstream of patients with septic shock, the most severe form of sepsis, to determine the relationship between bacterial load and clinical outcomes. We hypothesise that the bacterial load on presentation and the change in bacterial load over time determines survival and the evolution of organ failure in patients with septic shock.
Antibiotics have different effects on our own bacterial ecology, with sometimes unexpected detrimental effects. In this project, we will study this in detail and particularly address the question of 'good' and 'bad' antibiotics and how to identify them. National antibiotic policy and the deployment of 'decontamination' strategies in the critically ill are directly related issues and we expect to inform these important policy debates.